32 participants
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-07
- Start Date:
- 2023-08-28
- Completion:
- 2027-01-01
Conditions
- Esophagus Adenocarcinoma
Interventions
- DRUG
- RADIATION
No Results Yet